PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase InhibitorsMichael E. Stokes, David Surguladze, Crissy Dudgeon et al.|Clinical Cancer Research|2023Cited by 27
Discovery of HC-7366: An Orally Bioavailable and Efficacious GCN2 Kinase ActivatorChristopher G. Thomson, Savithri Ramurthy, Thomas D. Aicher et al.|Journal of Medicinal Chemistry|2024Cited by 16